Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population

European Journal of Endocrinology

Volumn 170, Issue 1, 2014, Pages 109-119

  Liu, Bing Li ^a   Yang, Shao Ying ^a   Liu, Wei ^a   Xue, Li Qiong ^a   Chen, Xia ^b   Pan, Chun Ming ^a   Gu, Zhao Hui ^a   Zhan, Ming ^a   Zhang, Xiao Mei ^c   Liang, Jun ^d   Gao, Guan Qi ^e   Du, Wen Hua ^e   Yuan, Guo Yue ^f   Ying, Ru ^g   Zhao, Shuang Xia ^a   Song, Huai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c BENGBU MEDICAL COLLEGE   (China)

^d XUZHOU CENTRAL HOSPITAL   (China)

^e LINYI PEOPLE'S HOSPITAL   (China)

^f JIANGSU UNIVERSITY   (China)

^g ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TSHR GENE;

ANTITHYROID AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; COMBINED MODALITY THERAPY; DRUG RESISTANCE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; IODINE RADIOISOTOPES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIOPHARMACEUTICALS; RECEPTORS, THYROTROPIN; REPRODUCIBILITY OF RESULTS;

EID: 84890524473     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0517     Document Type: Article

References (31)

1. Brix TH, Christensen K, Holm NV, Harvald B & Hegedus L. A population-based study of Graves' disease in Danish twins. Clinical Endocrinology 1998 48 397-400. (doi:10.1046/j.1365-2265.1998.00450.x)
2. Brix TH, Kyvik KO, Christensen K & Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. Journal of Clinical Endocrinology and Metabolism 2001 86 930-934. (doi:10.1210/jc.86.2.930)
3. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 423 506-511. (doi:10.1038/nature01621)
4. Simmonds MJ & Gough SC. The search for the genetic contribution to autoimmune thyroid disease: the never ending story? Brief Functional Genomics 2011 10 77-90. (doi:10.1093/bfgp/elq036)
5. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA et al. Regression mapping of association between the human leukocyte antigen region and Graves' disease. American Journal of Human Genetics 2005 76 157-163. (doi:10.1086/426947)
6. Simmonds MJ, Howson JM, Heward JM, Carr-Smith J, Franklyn JA, Todd JA & Gough SC. A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Human Molecular Genetics 2007 16 2149-2153. (doi:10.1093/hmg/ddm165)
7. Tomer Y. Genetic Susceptibility to Autoimmune Thyroid Disease: Past, Present, and Future. Thyroid 2010 20 715-725. (doi:10.1089/thy.2010.1644)
8. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, Shen M et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nature Genetics 2011 43 897-901. (doi:10.1038/ng.898)
9. Zhao SX, Xue LQ, Liu W, Gu ZH, Pan CM, Yang SY, Zhan M, Wang HN, Liang J, Gao GQ et al. Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis. Human Molecular Genetics 2013 22 3347-3362. (doi:10.1093/hmg/ddt183)
10. Szymanski K, Bednarczuk T, Krajewski P & Ploski R. The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population. Tissue Antigens 2012 79 380-383. (doi:10.1111/j.1399-0039.2012.01854.x)
11. Cooper JD, Simmonds MJ, Walker NM, Burren O, Brand OJ, Guo H, Wallace C, Stevens H, Coleman G, Franklyn JA et al. Seven newly identified loci for autoimmune thyroid disease. Human Molecular Genetics 2012 21 5202-5208. (doi:10.1093/hmg/dds357)
12. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA & Gough SC. Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 1998 8 777-780. (doi:10.1089/thy.1998.8.777)
13. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB & Morris JC. Germline polymorphism of codon 727 of human thyroidstimulating hormone receptor is associated with toxic multinodular goiter. Journal of Clinical Endocrinology and Metabolism 1999 84 3328-3335. (doi:10.1210/jc.84.9. 3328)
14. Simanainen J, Kinch A, Westermark K, Winsa B, Bengtsson M, Schuppert F, Westermark B & Heldin NE. Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants. Thyroid 1999 9 7-11. (doi:10.1089/thy.1999.9.7)
15. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI & Nosikov VV. Complex association analysis of Graves' disease using a set of polymorphic markers. Molecular Genetics and Metabolism 2000 70 214-218. (doi:10.1006/mgme.2000.3007)
16. Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G & Balazs C. Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. European Journal of Immunogenetics 2000 27 17-23. (doi:10.1046/j.1365-2370.2000.00187.x)
17. Muhlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ & Heufelder AE. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. Journal of Clinical Endocrinology and Metabolism 2000 85 2640-2643. (doi:10.1210/jc.85.8.2640)
18. Ban Y, Greenberg DA, Concepcion ES & Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 2002 12 1079-1083. (doi:10.1089/105072502321085171)
19. Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI & Nosikov VV. Further studies of genetic susceptibility to Graves' disease in a Russian population. Medical Science Monitor 2002 8 CR180-CR184.
20. Ho SC, Goh SS & Khoo DH. Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 2003 13 523-528. (doi:10.1089/105072503322238773)
21. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y & Akamizu T. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. Journal of Clinical Endocrinology and Metabolism 2005 90 2898-2903. (doi:10.1210/jc.2004-2148)
22. Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves'disease. Human Molecular Genetics 2009 18 1704-1713. (doi:10.1093/hmg/ ddp087)
23. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007 39 1329-1337. (doi:10.1038/ng.2007.17)
24. Feldt-Rasmussen U, Schleusener H & Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. Journal of Clinical Endocrinology and Metabolism 1994 78 98-102. (doi:10.1210/jc.78.1.98)
25. Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, Hayashi S & Hanafusa T. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease. Clinical Endocrinology 2003 58 550-555. (doi:10.1046/j.1365-2265.2003.01625.x)
26. Aulchenko YS, Struchalin MV & van Duijn CM. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 2010 11 134. (doi:10.1186/1471-2105-11-134)
27. Gustavsson B, Eklof C, Westermark K, Westermark B & Heldin NE. Functional analysis of a variant of the thyrotropin receptor gene in a family with Graves' disease. Molecular and Cellular Endocrinology 1995 111 167-173. (doi:10.1016/0303-7207(95)03562-L)
28. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K et al. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 2000 10 851-858. (doi:10.1089/thy.2000.10.851)
29. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA et al. Association of the TSHR gene with Graves' disease: the first disease specific locus. European Journal of Human Genetics 2005 13 1223-1230. (doi:10.1038/sj.ejhg.5201485)
30. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA & Seissler J. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. . Hormone and Metabolic Research 2004 36 92-96. (doi:10.1055/s-2004-814217)
31. Eckstein A, Mann K, Kahaly GJ, Grussendorf M, Reiners C, Feldkamp J, Quadbeck B, Bockisch A & Schott M. Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology. Medizinische Klinik 2009 104 343-348. (doi:10.1007/s00063-009-1072-0)